Australia
08048032296
+918788624929
Insomnia / sleeping medicine

Eszopinap - Eszopiclone Tablets USP 3 mg

In stockcod not available
Phone Number

08048032296

Please keep 0 before dialling the number.

Email Address lumenimpex@gmail.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Address Canberra ACT, Australia

Australia, Australia, 2600

Description

Eszopinap (Eszopiclone Tablets USP 3 mg) is a prescription medication primarily used for the short-term treatment of insomnia in adults. Primary Medical UsesImproving Sleep Onset: It helps individuals who have difficulty falling asleep to drift off much faster. Improving Sleep Maintenance: It helps individuals who struggle with staying asleep by reducing frequent nighttime awakenings. Enhancing Sleep Quality: By facilitating a full, uninterrupted sleep cycle, it promotes a more restful and restorative night's rest.

Keywords

Other Products

view all

Card 2

product image
Cardiac medicine

Rozavel A Capsules (a combination of Gastro-resistant Aspirin and Rosuvastatin) are primarily prescribed to prevent heart attacks, strokes, and angina in individuals with high cholesterol or established cardiovascular disease. This medication targets two major risk factors simultaneously by lowering blood lipid levels and preventing the formation of dangerous blood clots.

Card 2

product image
Anti-inflammatory Cream

Betnovate Skin Cream (20g) is a potent topical corticosteroid medication primarily used to treat severe inflammatory, allergic, and itchy skin conditions. Its active ingredient, Betamethasone Valerate I.P. (0.1% w/w), works by blocking the release of specific chemical messengers (prostaglandins) in the body that trigger swelling, redness, pain, and itching.

Card 2

product image
Antiplatelet Medicine

Cilostaheal 100 Tablets (containing Cilostazol 100 mg) are primarily prescribed to treat intermittent claudication, a symptom of peripheral vascular disease characterized by muscle pain, cramping, numbness, or weakness in the legs during physical activity like walking.